The overexpression of IL-7 in tumor tissue as compared to patient-matched normal tissue was significantly stronger in Stage 3/4 (T3/4) cancers than in less advanced Stage 1/2 (T1/2) cancers. The gene discussed is IL7; the disease is cancer.